Medpace Holdings, Inc. Deferred Tax Liabilities, Gross
Medpace Holdings, Inc. (MEDP) had Deferred Tax Liabilities, Gross of $68.88 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-10
- 2025-12-31: Deferred Tax Liabilities, Gross $68.88M.
- 2024-12-31: Deferred Tax Liabilities, Gross $62.12M.
- 2023-12-31: Deferred Tax Liabilities, Gross $55.45M.
- 2022-12-31: Deferred Tax Liabilities, Gross $47.13M.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $68.88M 10-K · filed 2026-02-10 | |
| 2024-12-31 | $62.12M 10-K · filed 2026-02-10 | |
| 2023-12-31 | $55.45M 10-K · filed 2025-02-11 | |
| 2022-12-31 | $47.13M 10-K · filed 2024-02-13 | |
| 2021-12-31 | $35.87M 10-K · filed 2023-02-14 | |
| 2020-12-31 | $30.51M 10-K · filed 2022-02-15 | |
| 2019-12-31 | $25.80M 10-K · filed 2021-02-16 | |
| 2018-12-31 | $19.61M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $21.23M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $33.97M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $20.51M 10-Q · filed 2016-11-03 | |
| 2015-12-31 | $39.20M 10-K · filed 2017-02-28 | $21.10M 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |